RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Tofacitinib in Patients with Active RA with an Inadequate Response to Tumor Necrosis Factor Inhibitors
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 13
SP 11
OP 12
DO 10.1177/155989771113003
UL http://mdc.sagepub.com/content/11/13/11.abstract
AB An oral Janus kinase inhibitor, in combination with methotrexate, led to significant improvements in a treatment-refractory rheumatoid arthritis population with no significant safety concerns. This article discusses the Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of 2 Doses of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate With Inadequate Response to TNF Inhibitors study [ORAL Sync; NCT00960440].